• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚(ADP - 核糖)聚合酶的酶学性质:自身修饰位点及NAD酶活性的表征

Enzymological properties of poly(ADP-ribose)polymerase: characterization of automodification sites and NADase activity.

作者信息

Desmarais Y, Ménard L, Lagueux J, Poirier G G

机构信息

Laboratoire du Métabolisme du poly ADP-ribose, Endocrinologie Moléculaire, CHUL, Ste-Foy, Canada.

出版信息

Biochim Biophys Acta. 1991 Jun 24;1078(2):179-86. doi: 10.1016/0167-4838(91)99007-f.

DOI:10.1016/0167-4838(91)99007-f
PMID:1648406
Abstract

We have characterized the effect of poly(ADP-ribose) polymerase automodification on the enzyme's activities, which include poly(ADP-ribose) synthesis and NADase activity. The apparent Km of the enzyme for NAD+ during polymer synthesis is higher than the one measured for alternate NADase activity. Furthermore, we have found that there are 28 automodification sites, in contrast to the 15 sites (postulated to be on the 15 glutamic acids) reported to be present in the automodification domain. For the first time, we show that some of these acceptor sites are outside the reported automodification domain (15 kDa); we demonstrate automodification in the NAD+ binding domain (55.2 kDa) and the DNA binding domain (42.5 kDa). We have analyzed the relationship between the number of sites modified on poly(ADP-ribose) polymerase and its effect on the polymerization activity and its alternate NADase activity. Automodification greatly altered both enzyme activities, decreasing both polymer synthesis and alternate NADase activity.

摘要

我们已经表征了聚(ADP - 核糖)聚合酶自身修饰对该酶活性的影响,这些活性包括聚(ADP - 核糖)合成和NAD酶活性。在聚合物合成过程中,该酶对NAD⁺的表观Km高于为交替NAD酶活性测定的值。此外,我们发现有28个自身修饰位点,与报道的自身修饰结构域中存在的15个位点(假定位于15个谷氨酸上)形成对比。我们首次表明,其中一些受体位点在报道的自身修饰结构域(15 kDa)之外;我们在NAD⁺结合结构域(55.2 kDa)和DNA结合结构域(42.5 kDa)中证明了自身修饰。我们分析了聚(ADP - 核糖)聚合酶上修饰位点的数量与其对聚合活性和交替NAD酶活性的影响之间的关系。自身修饰极大地改变了这两种酶活性,降低了聚合物合成和交替NAD酶活性。

相似文献

1
Enzymological properties of poly(ADP-ribose)polymerase: characterization of automodification sites and NADase activity.聚(ADP - 核糖)聚合酶的酶学性质:自身修饰位点及NAD酶活性的表征
Biochim Biophys Acta. 1991 Jun 24;1078(2):179-86. doi: 10.1016/0167-4838(91)99007-f.
2
NAD+ analogs substituted in the purine base as substrates for poly(ADP-ribosyl) transferase.在嘌呤碱基中被取代的NAD+类似物作为聚(ADP-核糖)转移酶的底物。
FEBS Lett. 1996 Nov 11;397(1):17-21. doi: 10.1016/s0014-5793(96)01137-4.
3
Poly(ADP-ribose) synthetase. The DNA binding domain and the automodification domain.聚(ADP - 核糖)合成酶。DNA结合结构域和自身修饰结构域。
J Biol Chem. 1982 Jun 10;257(11):6102-5.
4
Properties of poly(ADP-ribose) synthetase and ADP-ribosyl histone splitting enzyme.聚(ADP - 核糖)合成酶和ADP - 核糖基组蛋白裂解酶的特性
Princess Takamatsu Symp. 1983;13:121-8.
5
Poly(ADP-ribose) polymerase is a catalytic dimer and the automodification reaction is intermolecular.聚(ADP - 核糖)聚合酶是一种催化性二聚体,且自身修饰反应是分子间的。
J Biol Chem. 1993 Oct 25;268(30):22575-80.
6
A shuttle mechanism for DNA-protein interactions. The regulation of poly(ADP-ribose) polymerase.一种DNA-蛋白质相互作用的穿梭机制。聚(ADP-核糖)聚合酶的调控
Eur J Biochem. 1982 Oct;127(3):579-85.
7
Two proteolytic degradation products of calf-thymus poly(ADP-ribose) polymerase are efficient ADP-ribose acceptors. Implications for polymerase architecture and the automodification of the polymerase.
Eur J Biochem. 1983 Feb 1;130(2):309-14. doi: 10.1111/j.1432-1033.1983.tb07153.x.
8
Modification of the ADP-ribosyltransferase and NAD glycohydrolase activities of a mammalian transferase (ADP-ribosyltransferase 5) by auto-ADP-ribosylation.通过自身 ADP-核糖基化对哺乳动物转移酶(ADP-核糖基转移酶 5)的 ADP-核糖基转移酶和 NAD 糖水解酶活性进行修饰。
J Biol Chem. 1999 Nov 5;274(45):31797-803. doi: 10.1074/jbc.274.45.31797.
9
3'-Deoxy-NAD+ as a substrate for poly(ADP-ribose)polymerase and the reaction mechanism of poly(ADP-ribose) elongation.3'-脱氧-NAD+作为聚(ADP-核糖)聚合酶的底物及聚(ADP-核糖)延伸的反应机制。
J Biol Chem. 1988 Nov 25;263(33):17690-6.
10
Poly(ADP-ribose) synthesis and degradation in mammalian nuclei.哺乳动物细胞核中聚(ADP-核糖)的合成与降解
Anal Biochem. 1992 Jun;203(2):252-8. doi: 10.1016/0003-2697(92)90310-4.

引用本文的文献

1
Deciphering the dark side of histone ADP-ribosylation: what structural features of damaged nucleosome regulate the activities of PARP1 and PARP2.解读组蛋白ADP核糖基化的阴暗面:受损核小体的哪些结构特征调节PARP1和PARP2的活性。
Nucleic Acids Res. 2025 Sep 5;53(17). doi: 10.1093/nar/gkaf864.
2
PARP enzyme de novo synthesis of protein-free poly(ADP-ribose).聚(ADP - 核糖)聚合酶(PARP)酶从头合成无蛋白质的聚(ADP - 核糖)。
Mol Cell. 2024 Dec 19;84(24):4758-4773.e6. doi: 10.1016/j.molcel.2024.10.024. Epub 2024 Nov 12.
3
Regulation of Biomolecular Condensates by Poly(ADP-ribose).
多聚(ADP-核糖)对生物分子凝聚物的调控。
Chem Rev. 2023 Jul 26;123(14):9065-9093. doi: 10.1021/acs.chemrev.2c00851. Epub 2023 Apr 28.
4
Inhibitors of PARP: Number crunching and structure gazing.PARP 抑制剂:数字运算与结构观察。
Proc Natl Acad Sci U S A. 2022 Mar 15;119(11):e2121979119. doi: 10.1073/pnas.2121979119. Epub 2022 Mar 8.
5
Dual function of HPF1 in the modulation of PARP1 and PARP2 activities.HPF1 在调节 PARP1 和 PARP2 活性方面的双重功能。
Commun Biol. 2021 Nov 3;4(1):1259. doi: 10.1038/s42003-021-02780-0.
6
HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase.HPF1 和核小体介导 PARP1 从聚合酶到水解酶活性的剧烈转变。
Elife. 2021 Mar 8;10:e65773. doi: 10.7554/eLife.65773.
7
The Multifactorial Role of PARP-1 in Tumor Microenvironment.聚(ADP-核糖)聚合酶-1(PARP-1)在肿瘤微环境中的多因素作用
Cancers (Basel). 2020 Mar 20;12(3):739. doi: 10.3390/cancers12030739.
8
Emerging roles of eraser enzymes in the dynamic control of protein ADP-ribosylation.新兴的橡皮擦酶在蛋白质 ADP-核糖基化的动态调控中的作用。
Nat Commun. 2019 Mar 12;10(1):1182. doi: 10.1038/s41467-019-08859-x.
9
Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.聚(ADP-核糖)化由 PARP1 介导:反应机制和调节蛋白。
Nucleic Acids Res. 2019 May 7;47(8):3811-3827. doi: 10.1093/nar/gkz120.
10
Poly(adenosine diphosphate-ribose) polymerase as therapeutic target: lessons learned from its inhibitors.聚(二磷酸腺苷-核糖)聚合酶作为治疗靶点:从其抑制剂中吸取的经验教训。
Oncotarget. 2017 Jul 25;8(30):50221-50239. doi: 10.18632/oncotarget.16859.